← Who reports today · Health Care
DXCM earnings date & Q2 2026 results · Dexcom
US GAAP · $M · vs Q2 2025 · quarter ended 06/30/2026 · reported 07/30/2026
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. · Text: Wikipedia, CC BY-SA 4.0, abridged
More about the company
It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland.
Key growth driver: GAAP operating margin expanded 590 basis points to 24.3% of revenue, while U.S. revenue grew 11% and international revenue grew 19%. · by the Q2 2026 report
When is DXCM’s next earnings date?
Thursday, October 29, 2026estimated
Expected around Oct 29 — based on last year’s report on Oct 30, 2025. We have not yet seen the company's announcement of the date.
How we estimate
The estimate is the date of the same-quarter report a year ago, per the company’s SEC filing, moved forward 52 weeks (same weekday). Companies usually keep the same week; the date will be replaced once DXCM announces it.
Same quarter a year ago (ended September 30, 2025): revenue $1.21B, EPS (GAAP) $0.70
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
What time does DXCM report? Usually after market close: the last 4 results releases reached the SEC at 4:03 pm, 4:02 pm, 4:03 pm, 7:30 am ET.
Last report: Jul 30, 2026 (Q2 2026) — broken down in the Sankey chart below. Dates: company announcements; past dates and times — SEC 8-K filings. Who else reports this week →
All figures in $M.
Revenue
$1,308
+13.1%
Gross profit
$830
+20.5%
63.4% margin
Operating income
$318
+49.7%
24.3% margin
Net income
$249
+38.5%
$0.64/sh · 19.0% margin
Verdict: Dexcom's revenue grew 13.1% to $1.31B, operating income jumped 49.7% to $318.3M, and net income rose 38.5% to $249.1M, or $0.64 per diluted share.
Source and notation
Source: DXCM press release, 8-K EX-99.1 of 07/30/2026 (SEC EDGAR).
Open the chart as a PNG image ↗ · for sharing and presentations · free to reuse, CC BY 4.0
DXCM earnings history: past report dates
| Jul 30, 2026 Thu | 4:03 pmafter market close | Jun 30, 2026 | $1.3B+13% y/y | $0.64+42% y/y |
| Apr 30, 2026 Thu | 4:02 pmafter market close | Mar 31, 2026 | $1.2B+15% y/y | $0.51+89% y/y |
| Jan 12, 2026 Mon | 7:30 ambefore market open | Dec 31, 2025 | ≈$1.3B+13% y/y | ≈$0.67+81% y/y |
| Oct 30, 2025 Thu | 4:02 pmafter market close | Sep 30, 2025 | $1.2B+22% y/y | $0.70+106% y/y |
| Jul 30, 2025 Wed | 4:02 pmafter market close | Jun 30, 2025 | $1.2B+15% y/y | $0.45+29% y/y |
| May 1, 2025 Thu | 4:03 pmafter market close | Mar 31, 2025 | $1.0B+12% y/y | $0.27−25% y/y |
| Jan 13, 2025 Mon | 7:31 ambefore market open | Dec 31, 2024 | ≈$1.1B+8% y/y | ≈$0.37−39% y/y |
| Oct 24, 2024 Thu | 4:04 pmafter market close | Sep 30, 2024 | $994M+2% y/y | $0.34+17% y/y |
| Jul 25, 2024 Thu | 4:05 pmafter market close | Jun 30, 2024 | $1.0B+15% y/y | $0.35+25% y/y |
| Apr 25, 2024 Thu | 4:05 pmafter market close | Mar 31, 2024 | $921M+24% y/y | $0.36+200% y/y |
| Jan 8, 2024 Mon | 8:02 ambefore market open | Dec 31, 2023 | ≈$1.0B+27% y/y | ≈$0.61+177% y/y |
| Oct 26, 2023 Thu | 4:04 pmafter market close | Sep 30, 2023 | $975M+27% y/y | $0.29+21% y/y |
| Jul 27, 2023 Thu | 4:05 pmafter market close | Jun 30, 2023 | $871M+25% y/y | $0.28+133% y/y |
| Apr 27, 2023 Thu | 4:05 pmafter market close | Mar 31, 2023 | $742M+18% y/y | $0.12−48% y/y |
| Jan 9, 2023 Mon | 8:03 ambefore market open | Dec 31, 2022 | ≈$815M+17% y/y | ≈$0.22 |
| Oct 27, 2022 Thu | 4:05 pmafter market close | Sep 30, 2022 | $770M+18% y/y | $0.24+14% y/y |
| Jul 28, 2022 Thu | 4:07 pmafter market close | Jun 30, 2022 | $696M+17% y/y | $0.12−37% y/y |
| Apr 28, 2022 Thu | 4:08 pmafter market close | Mar 31, 2022 | $629M+25% y/y | $0.23+64% y/y |
| Jan 10, 2022 Mon | 8:00 ambefore market open | Dec 31, 2021 | ≈$698M+23% y/y | ≈−$0.01 |
| Oct 28, 2021 Thu | 4:06 pmafter market close | Sep 30, 2021 | $650M+30% y/y | $0.21+17% y/y |
| Jul 29, 2021 Thu | 4:05 pmafter market close | Jun 30, 2021 | $595M+32% y/y | $0.19+58% y/y |
| Apr 29, 2021 Thu | 4:03 pmafter market close | Mar 31, 2021 | $505M+25% y/y | $0.14+180% y/y |
| Jan 11, 2021 Mon | 7:39 ambefore market open | Dec 31, 2020 | ≈$569M+23% y/y | ≈$0.97+288% y/y |
| Oct 26, 2020 Mon | 5:24 pmafter market close | Sep 30, 2020 | $501M+26% y/y | $0.18+38% y/y |
| Jul 28, 2020 Tue | 4:08 pmafter market close | Jun 30, 2020 | $452M+34% y/y | $0.12 |
| Apr 28, 2020 Tue | 4:07 pmafter market close | Mar 31, 2020 | $405M+44% y/y | $0.05 |
| Jan 13, 2020 Mon | 7:33 ambefore market open | Dec 31, 2019 | $463M+37% y/y | $0.25 |
| Nov 6, 2019 Wed | 4:06 pmafter market close | Sep 30, 2019 | $396M+49% y/y | $0.13+0% y/y |
| Jul 31, 2019 Wed | 4:08 pmafter market close | Jun 30, 2019 | $336M+39% y/y | −$0.03 |
| May 1, 2019 Wed | 4:13 pmafter market close | Mar 31, 2019 | $281M+52% y/y | −$0.07+0% y/y |
| Jan 7, 2019 Mon | 8:01 ambefore market open | Dec 31, 2018 | $338M+53% y/y | −$0.51 |
| Nov 6, 2018 Tue | 4:04 pmafter market close | Sep 30, 2018 | $267M+44% y/y | $0.13 |
| Aug 1, 2018 Wed | 4:05 pmafter market close | Jun 30, 2018 | $243M+42% y/y | $0.09+800% y/y |
| May 2, 2018 Wed | 4:07 pmafter market close | Mar 31, 2018 | $184M+30% y/y | −$0.07+42% y/y |
| Jan 8, 2018 Mon | 4:10 pmafter market close | Dec 31, 2017 | $221M+29% y/y | −$0.03−50% y/y |
| Nov 1, 2017 Wed | 4:04 pmafter market close | Sep 30, 2017 | $185M+24% y/y | $0.00 |
| Aug 1, 2017 Tue | 4:07 pmafter market close | Jun 30, 2017 | $171M+24% y/y | $0.01 |
| May 2, 2017 Tue | 4:07 pmafter market close | Mar 31, 2017 | $142M+22% y/y | −$0.12−100% y/y |
| Jan 10, 2017 Tue | 8:36 ambefore market open | Dec 31, 2016 | $171M+31% y/y | −$0.02 |
| Nov 1, 2016 Tue | 4:05 pmafter market close | Sep 30, 2016 | $149M+41% y/y | −$0.05+62% y/y |
| Aug 2, 2016 Tue | 4:05 pmafter market close | Jun 30, 2016 | $137M+47% y/y | −$0.06−500% y/y |
| Apr 27, 2016 Wed | 4:05 pmafter market close | Mar 31, 2016 | $116M+60% y/y | −$0.06−50% y/y |
| Jan 12, 2016 Tue | 8:30 ambefore market open | Dec 31, 2015 | $131M+55% y/y | $0.01+0% y/y |
| Oct 14, 2015 Wed | 4:26 pmafter market close | Sep 30, 2015 | $105M+52% y/y | −$0.13−550% y/y |
| Aug 5, 2015 Wed | 4:05 pmafter market close | Jun 30, 2015 | $93M+59% y/y | −$0.01+50% y/y |
| Apr 29, 2015 Wed | 4:11 pmafter market close | Mar 31, 2015 | $73M+55% y/y | −$0.04+0% y/y |
| Jan 13, 2015 Tue | 8:30 ambefore market open | Dec 31, 2014 | $84M+63% y/y | $0.01 |
| Nov 6, 2014 Thu | 4:06 pmafter market close | Sep 30, 2014 | $69M+61% y/y | −$0.02 |
| Aug 6, 2014 Wed | 4:06 pmafter market close | Jun 30, 2014 | $59M+64% y/y | −$0.02 |
| May 1, 2014 Thu | 4:09 pmafter market close | Mar 31, 2014 | $47M+59% y/y | −$0.04 |
Show all 50 reports since 2014Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
Dexcom: 15-year financials
| 2025 | 4,662 | 912 | 836 | 1,077 |
| 2024 | 4,033 | 600 | 576 | 631 |
| 2023 | 3,622 | 598 | 542 | 512 |
| 2022 | 2,910 | 391 | 341 | 305 |
| 2021 | 2,449 | 266 | 217 | 53.3 |
| 2020 | 1,927 | 300 | 550 | 277 |
| 2019 | 1,476 | 142 | 101 | 135 |
| 2018 | 1,032 | −186 | −127 | 56.1 |
| 2017 | 719 | −42.5 | −50.2 | 26 |
| 2016 | 573 | −63.9 | −65.6 | 0.5 |
| 2015 | 402 | −57.1 | −57.6 | 15.7 |
| 2014 | 259 | −21.5 | −22.4 | 7.4 |
| 2013 | 160 | −28.9 | −29.8 | −5.5 |
| 2012 | 99.9 | −55.7 | −54.5 | −42.6 |
| 2011 | 76.3 | −44.8 | −44.7 | −38.1 |
Show all 15 yearsShow fewer
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
Shareholders’ equity at Jun 30, 2026: $2.6B (41% of total assets). Compare with other S&P 500 companies →
Included in screener lists: S&P 500 companies with revenue growth 10 years in a row
Dexcom (DXCM) earnings: FAQ
When is DXCM's next earnings date?
We have not yet seen an announcement of the date from Dexcom (DXCM). Based on last year's report on Oct 30, 2025, the next report is expected around Oct 29, 2026.
What time does DXCM report earnings?
Dexcom usually reports after market close: its latest results release was filed with the SEC at 4:03 pm ET on Jul 30, 2026.
When did DXCM last report earnings?
Dexcom reported Q2 2026 results on Jul 30, 2026.
Where can I find Dexcom's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to DXCM's filings; this page breaks the latest report down in a Sankey chart.
What was DXCM's net income in Q2 2026?
Dexcom reported net income of $249M for Q2 2026 (+38.5% year over year), under US GAAP.
How has Dexcom's revenue changed since 2011?
Per its 10-K filings, revenue grew 61.1x: $76M in 2011 and $4,662M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
How this page was made: the figures come from the company's own report on SEC EDGAR; the summary and nuances were drafted by our model from that report — two independent automated readings of the release had to match, and every number in the text was checked against it. Figures checked against the filing on 10/16/2026. How we make the breakdowns · Report an error
More reports: ELV · Q2 2026 · GEHC · Q2 2026 · GILD · Q2 2026 · HCA · Q2 2026 · ILMN · Q2 2026 · INCY · Q2 2026 · IQV · Q2 2026 · ISRG · Q2 2026 · JNJ · Q3 2026 · LH · Q2 2026 · all reports